Literature DB >> 9566883

The N-terminal domain of IkappaB alpha masks the nuclear localization signal(s) of p50 and c-Rel homodimers.

M Latimer1, M K Ernst, L L Dunn, M Drutskaya, N R Rice.   

Abstract

Members of the Rel/NF-kappaB family of transcription factors are related to each other over a region of about 300 amino acids called the Rel Homology Domain (RHD), which governs DNA binding, dimerization, and binding to inhibitor. At the C-terminal end of the RHD, each protein has a nuclear localization signal (NLS). The crystal structures of the p50 and RelA family members show that the RHD consists of two regions: an N-terminal section which contains some of the DNA contacts and a C-terminal section which contains the remaining DNA contacts and controls dimerization. In unstimulated cells, the homo- or heterodimeric Rel/NF-kappaB proteins are cytoplasmic by virtue of binding to an inhibitor protein (IkappaB) which somehow masks the NLS of each member of the dimer. The IkappaB proteins consist of an ankyrin-repeat-containing domain that is required for binding to dimers and N- and C-terminal domains that are dispensable for binding to most dimers. In this study, we examined the interaction between IkappaB alpha and Rel family homodimers by mutational analysis. We show that (i) the dimerization regions of p50, RelA, and c-Rel are sufficient for binding to IkappaB alpha, (ii) the NLSs of RelA and c-Rel are not required for binding to IkappaB alpha but do stabilize the interaction, (iii) the NLS of p50 is required for binding to IkappaB alpha, (iv) only certain residues within the p50 NLS are required for binding, and (v) in a p50-IkappaB alpha complex or a c-Rel-IkappaB alpha complex, the N terminus of IkappaB alpha either directly or indirectly masks one or both of the dimer NLSs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566883      PMCID: PMC110643          DOI: 10.1128/MCB.18.5.2640

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

1.  Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA.

Authors:  F E Chen; D B Huang; Y Q Chen; G Ghosh
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

2.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.

Authors:  S Rogers; R Wells; M Rechsteiner
Journal:  Science       Date:  1986-10-17       Impact factor: 47.728

3.  The membrane-binding domain of ankyrin contains four independently folded subdomains, each comprised of six ankyrin repeats.

Authors:  P Michaely; V Bennett
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

4.  I kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motif.

Authors:  S Kumar; C Gélinas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

5.  The precursor of NF-kappa B p50 has I kappa B-like functions.

Authors:  N R Rice; M L MacKichan; A Israël
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

6.  I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.

Authors:  A A Beg; S M Ruben; R I Scheinman; S Haskill; C A Rosen; A S Baldwin
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

7.  Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein.

Authors:  C E Beisel; J F Edwards; L L Dunn; N R Rice
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.

Authors:  P A Ganchi; S C Sun; W C Greene; D W Ballard
Journal:  Mol Biol Cell       Date:  1992-12       Impact factor: 4.138

9.  Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel.

Authors:  T H Tan; G P Huang; A Sica; P Ghosh; H A Young; D L Longo; N R Rice
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

10.  Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3.

Authors:  E N Hatada; M Naumann; C Scheidereit
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  18 in total

1.  A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.

Authors:  T T Huang; N Kudo; M Yoshida; S Miyamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation.

Authors:  Xin Tong; Lei Yin; Raymond Washington; Daniel W Rosenberg; Charles Giardina
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

Review 3.  Cytokine-induced nuclear translocation of signaling proteins and their analysis using the inducible translocation trap system.

Authors:  Shella Saint Fleur; Hodaka Fujii
Journal:  Cytokine       Date:  2008-01-18       Impact factor: 3.861

4.  A Rac GTPase-activating protein, MgcRacGAP, is a nuclear localizing signal-containing nuclear chaperone in the activation of STAT transcription factors.

Authors:  Toshiyuki Kawashima; Ying Chun Bao; Yukinori Minoshima; Yasushi Nomura; Tomonori Hatori; Tetsuya Hori; Tatsuo Fukagawa; Toshiyuki Fukada; Noriko Takahashi; Tetsuya Nosaka; Makoto Inoue; Tomohiro Sato; Mutsuko Kukimoto-Niino; Mikako Shirouzu; Shigeyuki Yokoyama; Toshio Kitamura
Journal:  Mol Cell Biol       Date:  2009-01-21       Impact factor: 4.272

5.  Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.

Authors:  Patricia E Collins; Patrick A Kiely; Ruaidhrí J Carmody
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

6.  Mechanisms by which IkappaB proteins control NF-kappaB activity.

Authors:  S Simeonidis; D Stauber; G Chen; W A Hendrickson; D Thanos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

7.  Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.

Authors:  A Orian; A L Schwartz; A Israël; S Whiteside; C Kahana; A Ciechanover
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

8.  G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.

Authors:  Hui-Qi Hong; Jing Lu; Xiu-Li Fang; Yu-Hong Zhang; Yi Cai; Jing Yuan; Pei-Qing Liu; Jian-Tao Ye
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

Review 9.  The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.

Authors:  Arindam Dhar; Mathew R Young; Nancy H Colburn
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  Construction of a large scale integrated map of macrophage pathogen recognition and effector systems.

Authors:  Sobia Raza; Neil McDerment; Paul A Lacaze; Kevin Robertson; Steven Watterson; Ying Chen; Michael Chisholm; George Eleftheriadis; Stephanie Monk; Maire O'Sullivan; Arran Turnbull; Douglas Roy; Athanasios Theocharidis; Peter Ghazal; Tom C Freeman
Journal:  BMC Syst Biol       Date:  2010-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.